October 17, 2015
Article
Combining the chemotherapy streptozotocin with various mTOR inhibitors was found to effectively target tumors in preclinical studies for pancreatic neuroendocrine tumors (pNETs).
October 17, 2015
Article
Treatment with capecitabine and temozolomide is an effective therapy for patients with metastatic pancreatic neuroendocrine tumors.